Show simple item record

dc.contributor.authorPujades-Rodríguez, Mar
dc.contributor.authorDantony, Emmanuelle
dc.contributor.authorPinoges, Loretxu
dc.contributor.authorEcochard, René
dc.contributor.authorEtard, Jean-François
dc.contributor.authorCarrillo-Casas, Esther
dc.contributor.authorSzumilin, Elisabeth
dc.date.accessioned2012-01-18T17:28:28Z
dc.date.available2012-01-18T17:28:28Z
dc.date.issued2011-11
dc.identifier.citationToxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy. 2011, 6 (11):e28112 PLoS ONEen
dc.identifier.issn1932-6203
dc.identifier.pmid22132226
dc.identifier.doi10.1371/journal.pone.0028112
dc.identifier.urihttp://hdl.handle.net/10144/203633
dc.description.abstractTo compare the incidence and timing of toxicity associated with the use of a reduced dose of stavudine from 40 to 30 mg in first-line antiretroviral therapy (ART) for HIV treatment and to investigate associated risk factors.
dc.language.isoenen
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen
dc.titleToxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy.en
dc.contributor.departmentClinical Research Department, Epicentre, Paris, France. mar.pujades@epicentre.msf.orgen
dc.identifier.journalPLoS Oneen
refterms.dateFOA2019-03-04T09:34:06Z
html.description.abstractTo compare the incidence and timing of toxicity associated with the use of a reduced dose of stavudine from 40 to 30 mg in first-line antiretroviral therapy (ART) for HIV treatment and to investigate associated risk factors.


Files in this item

Thumbnail
Name:
Pujades D4T Toxicity.pdf
Size:
174.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record